Home / World Marketplace / Archive by category Global Health & Biotech (Page 90)

Archive by category Global Health & Biotech

MoonLake Immunotherapeutics Announces Landmark Phase 2 Results for Nanobody® Sonelokimab in Active Psoriatic Arthritis

MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis First placebo-controlled randomized trial in active psoriatic arthritis (PsA) using a Nanobody® to report positive topline results in support of potential best-in-class profile Primary endpoint ACR50 met with up to 47% (p<0.01 versus placebo) of patients on sonelokimab achieving ACR50 as early as [...]

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days SAN DIEGO, Nov. 03, 2023 (Korea Bizwire) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® De novo Cloning and Amplification kit on the BioXp 3250 and BioXp [...]

Internationally Renowned Public Health Expert Sten Vermund Appointed President of the Global Virus Network (GVN)

Brings Decades Of Infectious Disease Epidemiology & Prevention Experience Enhancing GVN’s Abilities To End Viral Threats & Advance Pandemic Preparedness BALTIMORE, Nov. 02, 2023 (Korea Bizwire) – The Global Virus Network (GVN) today announced the appointment of Sten Vermund, MD, PhD, as President of the GVN. Dr. Vermund is the Anna M.R. Lauder Professor of Public Health, former [...]

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.

Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers DURHAM, N.C., Nov. 02, 2023 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it has completed a multi-year effort to expand its clinical [...]

Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis

BOSTON, Nov. 02, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia. The Novotech research analyst team offers these expert reports monthly at no cost. These reports provide up-to-date information on global clinical trial activity, shedding light [...]

Wistar Scientists Engineer New NK Cell Engaging Immunotherapy Approaches to Target and Potentially Treat Recalcitrant Ovarian Cancer

Novel human Siglec-7 monoclonal and bispecific antibodies are being developed as potential future cancer immunotherapies PHILADELPHIA, PA, Nov. 01 (Korea Bizwire) — The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research, and collaborators, have engineered novel monoclonal antibodies that engage [...]

Philips Foundation Marks Five Years of Improving Access to Maternal Care in Sub-Saharan Africa and Sets Out Future Plans

Reaching 15 million people in the region in 2022 alone [1], the foundation sets out plans to ramp up collaboration with social entrepreneurs Amsterdam, the Netherlands and Nairobi, Kenya, November 1, 2023 (Korea Bizwire) – Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year by 2030, reports today on [...]

Malaysia Healthcare Promotes Regular Screenings for Breast Cancer Prevention

Enhancing accessibility to cutting-edge screening procedures for breast cancer early detection KUALA LUMPUR, Malaysia, Oct. 31, 2023 (Korea Bizwire) – Malaysia Healthcare encourages global citizens to practice regular examination and screenings as a crucial step in preventing breast cancer. With healthcare facilities that are equipped with innovative screening procedures, Malaysia Healthcare is committed to making [...]

Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules

Seed financing will drive commercial growth for Cambrium’s first product, NovaColl™, and accelerate expansion into new industries BERLIN, Oct. 31, 2023 (Korea Bizwire) – Synthetic biology startup Cambrium announces €8 Million in Seed financing, led by Essential Capital, along with SNR, Valor Equity Partners, and HOF Capital. The Berlin-based company brings novel molecules with previously [...]

King Faisal Specialist Hospital and Research Centre Utilizes Early Cancer Detection Technology for 50 Genes

RIYADH, Saudi Arabia, Oct. 31, 2023 (Korea Bizwire) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) has achieved a significant milestone by successfully conducting liquid biopsies on patients spanning various age groups. This innovative approach offers a safer alternative to conventional tissue biopsies. Notably, KFSH&RC stands out as the first healthcare facility in the [...]